The choice of drug from the standpoint of evidence-based medicine: case study of beta-blockers

被引：0
作者：
Martsevich, S. Yu. [1 ,2 ]
Kutishenko, N. P. [1 ]
Lukina, Yu. V. [1 ,2 ]
机构：
[1] State Res Ctr Prevent Med, Petroverigsky Per 10, Moscow 101990, Russia
[2] IM Setchenov First Moscow State Med Univ, Moscow 119991, Russia
来源：
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY | 2010年 / 6卷 / 06期
关键词：
drug choice; cardiovascular risk; beta-blockers;
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Basic principles of beta-blockers choice strategy are presented. Attention is focused on the facts concerning the evidence base for effects of various beta-blockers on the outcomes of cardiovascular diseases. Beta-blocker indications and safety of their long-term use are considered from this point of view. Convincing data about beta-blocker impact on the prognosis of cardiovascular disease should be the reason for any beta-blocker choice, as well as choice of their doses which were tested in large randomized trials.
引用
收藏
页码：876 / 881
页数：6
相关论文
共 30 条
  • [21] Beta-blockers in post-acute myocardial infarction patients: Drug prescription patterns from 2018 to Italy's first wave of the COVID-19 pandemic
    Olmastroni, Elena
    Galimberti, Federica
    Catapano, Alberico L.
    Tragni, Elena
    Casula, Manuela
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [22] N-of-1 trials to facilitate evidence-based deprescribing: Rationale and case study
    Goyal, Parag
    Safford, Monika M.
    Hilmer, Sarah N.
    Steinman, Michael A.
    Matlock, Daniel D.
    Maurer, Mathew S.
    Lachs, Mark S.
    Kronish, Ian M.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2022, 88 (10) : 4460 - 4473
  • [23] Micro-extraction by packed sorbent coupled on-line to a column-switching chromatography system - A case study on the determination of three beta-blockers in human urine
    Satinsky, Dalibor
    Sobek, Vojtech
    Lhotska, Ivona
    Solich, Petr
    MICROCHEMICAL JOURNAL, 2019, 147 : 60 - 66
  • [24] Treatment with Beta-Blockers and ACE-Inhibitors in Breast Cancer Patients Receiving Adjuvant Trastuzumab-Based Therapy and Developing Mild Cardiac Toxicity: A Prospective Study
    Geuna, Elena
    Lombardi, Pasquale
    Martinello, Rossella
    Garino, Davide
    Bonzano, Alessandro
    Galizia, Danilo
    Nuzzo, Annamaria
    Berchialla, Paola
    Becco, Paolo
    Mangioni, Monica
    De Zarlo, Lorena
    Montemurro, Filippo
    CANCERS, 2020, 12 (02)
  • [25] Comparison of Long-Term Clinical Implications of Beta-Blockade in Patients With Obstructive Airway Diseases Exposed to Beta-Blockers With Different β1-Adrenoreceptor Selectivity: An Italian Population-Based Cohort Study
    Sessa, Maurizio
    Mascolo, Annamaria
    Scavone, Cristina
    Perone, Ilaria
    Di Giorgio, Annalisa
    Tari, Michele
    Fucile, Annamaria
    De Angelis, Antonella
    Rasmussen, Daniel Bech
    Jensen, Magnus Thorsten
    Kragholm, Kristian
    Rossi, Francesco
    Capuano, Annalisa
    Sportiello, Liberata
    FRONTIERS IN PHARMACOLOGY, 2018, 9
  • [26] Do immigrants from Turkey, Pakistan and Yugoslavia receive adequate medical treatment with beta-blockers and statins after acute myocardial infarction compared with Danish-born residents? A register-based follow-up study
    Nana Folmann Hempler
    Finn Diderichsen
    Finn Breinholt Larsen
    Steen Ladelund
    Torben Jørgensen
    European Journal of Clinical Pharmacology, 2010, 66 : 735 - 742
  • [27] Do immigrants from Turkey, Pakistan and Yugoslavia receive adequate medical treatment with beta-blockers and statins after acute myocardial infarction compared with Danish-born residents? A register-based follow-up study
    Hempler, Nana Folmann
    Diderichsen, Finn
    Larsen, Finn Breinholt
    Ladelund, Steen
    Jorgensen, Torben
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 66 (07) : 735 - 742
  • [28] Association of beta-blockers and first-registered heart rhythm in out-of-hospital cardiac arrest: real-world data from population-based cohorts across two European countries
    Barcella, Carlo A.
    Eroglu, Talip E.
    Hulleman, Michiel
    Granfeldt, Asger
    Souverein, Patrick C.
    Mohr, Grimur H.
    Koster, Rudolph W.
    Wissenberg, Mads
    de Boer, Anthonius
    Torp-Pedersen, Christian
    Folke, Fredrik
    Blom, Marieke T.
    Gislason, Gunnar H.
    Tan, Hanno L.
    EUROPACE, 2020, 22 (08): : 1206 - 1215
  • [29] Changes in Adherence to Evidence-Based Medications in the First Year After Initial Hospitalization for Heart Failure Observational Cohort Study From 1994 to 2003
    Lamb, Darcy A.
    Eurich, Dean T.
    McAlister, Finlay A.
    Tsuyuki, Ross T.
    Semchuk, William M.
    Wilson, Thomas W.
    Blackburn, David F.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2009, 2 (03): : 228 - 235
  • [30] Do evidence-based treatments provide incremental benefits to patients with congestive heart failure already receiving angiotensin-converting enzyme inhibitors? A secondary analysis of one-year outcomes from the Assessment of Treatment with Lisinopril and Survival (ATLAS) study
    Majumdar, SR
    McAlister, FA
    Cree, M
    Chang, WC
    Packer, M
    Armstrong, PW
    CLINICAL THERAPEUTICS, 2004, 26 (05) : 694 - 703
123